Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.

Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma. J Clin Oncol. 2003 Jun 15; 21(12):2342-8.

View in: PubMed

subject areas

Adult
Aged
Antigens, Neoplasm
Cancer Vaccines
CD8-Positive T-Lymphocytes
Female
HLA-A2 Antigen
Humans
Interferon-gamma
Interleukin-12
Leukocytes, Mononuclear
Male
MART-1 Antigen
Melanoma
Middle Aged
Neoplasm Metastasis
Neoplasm Proteins
Recombinant Proteins
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
T-Lymphocytes
Treatment Outcome

authors with profiles

Thomas F. Gajewski